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Background: Pulmonary embolism (PE) has been associated with the risk of arterial cardiovascular events,
with diagnosis being difﬁcult in older adults. Multiple factors contribute to mortality and morbidity in
older adults. Hence, we aimed to investigate the difference of subsequent cardiovascular events (SCVE)
and demography between younger and older adults.
Methods:We undertook a retrospective cohort study using data from a 1100-bed urban medical center in
Taipei, Taiwan. All patients who presented to the emergency department with a documented diagnosis of
PE (ICD-9 of 415.19), from January 2003 to December 2008, were enrolled and speciﬁed into two age
groups. Clinical follow-up was conducted until December 2009, with a median time of 3.5 years. The
SCVE included new onset of ischemic stroke or heart attack and recurrence of PE. The time between
when a patient was presented to the ER and when the diagnosis took place was assessed.
Results: A total of 104 patients were studied, among which 58 patients were placed in the elderly group
( 65 years old) and 46 were placed in the young group (< 65 years old). There were signiﬁcantly more
females in the elderly group (n¼ 43; 74.1%; p< 0.05). Underlying morbidities including diabetes mellitus
(DM), chronic renal failure, hypertension, ischemic stroke, ischemic heart disease, and heart failure were
signiﬁcantly more predominant in the elderly group. There was no signiﬁcant difference between the two
groups in terms of clinical presentation and the incidence of massive PE. A total of 9 patients (8.7%) expired
during their hospital stay, with no difference between the two groups. SCVE showed only a signiﬁcant
difference among new ischemic heart disease (n¼ 6; 10.3%). There was a signiﬁcant difference in diagnosis
intervals between the two groups (elderly¼ 48.5 83.9 hours; young¼ 21.4 38.5 hours; < 0.05).
Conclusion: Diagnosis intervals in the elderly were widely variable. Rapid and precise diagnosis of PE in
the emergency department remains a challenge. Clinical presentations gave less useful information to
make a correct diagnosis of PE, especially in the elderly. There are more new episodes of ischemic heart
disease in the elderly followed by PE, but no signiﬁcant difference in the overall SCVE between the two
groups. The relationship between SCVE and age in patients with PE may need further evaluation.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Elderly patients with pulmonary embolism (PE) are at high risk
for morbidity and mortality because of the difﬁculty in diagnosis
and treatment1. Multiple factors contribute to mortality and
morbidity in older adults. Currently, the available information on
the long-term clinical course of patients with PE is essentiallyerest.
er 92, Section 2, Chungshan
ang).
iwan Society of Geriatric Emergenderived from a studywhich concluded that cancer, congestive heart
failure, and chronic lung disease are the risk factors of dying within
1 year2. Arterial thrombosis and venous thrombosis were catego-
rized as separate diseases in terms of pathogenesis and risk factors.
In recent years, arterial cardiovascular events, such as myocardial
infarction and stroke, have been added as important prognostic
factors for evaluating the clinical outcome of acute PE3e5. In
another study, the incidence of myocardial infarction was more
than twice as common and stroke was almost three times as
common in the 1st year following an episode of PE6. Despite
advances in the management of pulmonary embolism, little
contemporary data describes or compares the inﬂuence of age on
predisposing factors, diagnostic tests, or clinical presentation of PE7.cy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Demographic, co-morbidity, and symptoms for the two age groups.
Age S 65 y
(n¼ 58)
Age < 65 y
(n¼ 46)
Age, y SD 77 8 47 12
n (%) n (%)
Demographic and medical comorbidity
Sex (male)* 15 (25.9) 21(45.7)
Immobilization 18 (31) 8 (17.4)
Recent trauma 4 (6.9) 1 (2.2)
DM* 20 (34.5) 5(10.9)
Uremia* 8 (13.8) 0 (0)
Smoking 17 (29.3) 13 (28.3)
Hypertension* 44 (75.9) 19 (41.3)
Hx of stroke* 12 (20.7) 3 (6.5)
Hx of CAD* 18 (31) 5 (10.9)
Hx of DVT 5 (8.6) 3 (6.5)
CHF* 21 (36.2) 6 (13)
Active heparin use 6 (10.3) 2 (4.3)
Active chemotherapy 4 (6.9) 2 (4.3)
Recent procedural for central venous line 2 (3.4) 3 (6.5)
Symptoms
Hemoptysis 0 (0) 2 (4.3)
Short of breath 49 (84.5) 42 (91.3)
Chest pain 27 (46.6) 24 (52.2)
Fever 10 (17.2) 9 (19.6)
Cough 19 (32.8) 11 (23.9)
Shock 10 (17.2) 13 (28.3)
Syncope 11 (19) 13 (28.3)
Limb edema 20 (34.5) 16 (34.8)
Limb pain 13 (22.4) 11 (23.9)
DM¼ diabetes mellitus; CAD¼ coronary artery disease; DVT¼ deep venous
thrombosis; CHF¼ congestive heart failure.
*Signiﬁcantly different, p< 0.05.
Table 2
Diagnostic interval, severity, and prognosis for the two age groups.
Age  65 y
(n¼ 58)
Age < 65 y
(n¼ 46)
n (%) n (%)
Diagnostic interval*, h SD 48.5 83.9 21.4 38.5
Diagnosis made after 24 h (p¼ 0.053) 22 (37.9) 9 (19.6)
Severity
Massive PE (p¼ 0.105) 10 (17.2) 15 (32.6)
Prognosis
In-hospital mortality (p¼ 0.728) 6 (10.3) 3 (6.5)
New stroke (p¼ 0.103) 6 (10.3) 1 (2.2)
New AMI* 6 (10.3) 0 (0)
Recurrent PE (p¼ 0.237) 2 (3.4) 5 (10.9)
Cardiovascular events (p¼ 0.207) 13 (22.4) 6 (13)
ED¼ emergency department; PE¼ pulmonary embolism; AMI¼ acute myocardial
infarction.
Massive pulmonary embolism is deﬁned by systemic hypotension or cardiogenic
shock.
*Signiﬁcantly different, p< 0.05.
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PE. We aimed to investigate the difference in subsequent cardio-
vascular events (SCVE) between younger and older adults.
2. Methods
We undertook a retrospective cohort study, using data from
a 1100-bed urbanmedical center in Taipei, Taiwan. Patients, with an
objectively documented episode of PE (ICD-9 of 415.19), were
enrolled into this study if theywere> 18 years old and presented to
the emergency department between January 2003 and December
2008. The patients were divided into two groups based on age; in
one group, patients were < 65 years old and in the other, patients
were  65 years old. Objective diagnosis of PE included a high-
probability ventilation/perfusion lung scintigraphy, an abnormal
pulmonary angiography, or an abnormal spiral computed tomog-
raphy of the chest8. All medical records were reviewed by two
physicians regarding the presenting symptoms, clinical courses, the
laboratory results, and other diagnostic tests. Clinical follow-up
took place until December 2009, with a median time of 3.5 years.
Information about co-morbidity that may have added risks to the
development of PE were recorded, including diabetes mellitus
(DM), hypertension, cerebrovascular disease, cardiovascular disease,
uremia, congestive heart failure (CHF), history of coronary artery
disease (CAD), and history of deep venous thrombosis (DVT)9.
Certain factors inﬂuencing PE, such as the presence of prolonged
immobilization, smoking, malignancies on active parenteral
chemotherapy, recent major procedures on vascular interventions,
and recent trauma, were also obtained through medical record
reviews10.
Study design and deﬁnition: Prolonged immobilization was
deﬁned as being immobilized for > 1 week. Recent trauma was
deﬁned as an accident that occurred < 3 months ago. Recent major
vascular intervention indicated the need for insertion of a central
venous line or port-A within 2 weeks before presentation. For the
severity of disease, massive PE indicates systemic hypotension or
cardiogenic shock. Systemic hypotension is deﬁned as a systolic
arterial pressure < 90 mmHg or a drop in systolic arterial pressure
of  40 mmHg for at least 15 minutes11. SCVE included new onset
of ischemic stroke, acute myocardial infarction, and recurrence of
PE12. Acute myocardial infarction was deﬁned as the presence of
two of the following criteria: (1) typical ischemic chest pain of
acute onset; (2) elevation of troponin or creatinine kinase enzyme
and its MB fraction  5%; and (3) ECG changes including new,
dynamic ST/T changes in at least two consecutive leads. Ischemic
stroke was deﬁned as the presence of a new focal neurological
deﬁcit, conﬁrmed by a CT scan or magnetic resonance image,
lasting more than 24 hours12. Recurrent PE was deﬁned by having
one of the following criteria: (1) a new ﬁlling defect in a spiral CT or
pulmonary angiography; or (2) a new high probability perfusion
defect in a ventilation/perfusion lung scan8. We also assessed the
duration between emergency department (ED) presentation and
the time when a diagnosis of PE was made. Statistical analysis was
conducted by using SPSS software version 12.0 (SPSS Inc., Chicago
IL., USA). The Chi-square and Fisher’s exact tests were performed
for categorical variables. We used independent-samples t tests for
continuous variables. A p value of < 0.05 was the criterion for
statistical signiﬁcance.
3. Results
Between January 2003 and December 2008, we reviewed a total
of 104 consecutive patients diagnosed with PE, among which 58
patients were placed in the elderly group ( 65 years old) and 46
were placed in the young group (< 65 years old). Females were thepredominant sex in the elderly group (n¼ 43; 74.1%; p< 0.05).
Underlyingmorbidity including DM, uremia, hypertension, ischemic
stroke, coronary artery disease, and congestive heart failure were all
signiﬁcantly predominant in the elderly group (p< 0.05). There was
no signiﬁcant difference between the two groups with regards to
the clinical presenting symptoms; the two main complaints for
seeking medical help were shortness of breath and chest pain
(Table 1).
The diagnostic interval, severity of pulmonary embolism, and
prognosis were compared between the two groups (Table 2).
There was a signiﬁcant difference between the two groups with
regards to the average time from when they arrived at the
emergency department to the time their diagnosis was made
(average time¼ 48.5 83.9 hours in the elderly group; average
time¼ 21.4 38.5 hours in the young group; p< 0.05). Furthermore,
Y.-Y. Feng et al.92this timely trend demonstrated that the rate of late-diagnosis after
24 hours of presentation was higher in elderly patients (37.9%) as
compared to that of young patients (19.6%); p¼ 0.053. However,
with regards to the incidence of massive PE, there was no signiﬁ-
cant difference between two groups [elderly¼ 10 patients (17.2%);
young¼ 15 patients (32.6%); p¼ 0.105]. With regards to the
prognosis, 9 patients (8.7%) died during the stay in hospital and
there was no difference between the two groups [elderly¼ 6
patients (10.3%); young¼ 3 patients (6.5%); p¼ 0.728]. However,
the SCVE showed a signiﬁcant differencewith regards to new acute
myocardial infarction in the elderly group (6 patients, 10.3%,
p< 0.05).
4. Discussion
PE is the blockage of the main artery of one or both lungs;
however, the severity and duration of symptoms can vary greatly,
which makes PE diagnosis difﬁcult1,13. We attempted to determine
the different manifestations between elderly and young patients in
our study. Moreover, the main objective of this study was to
compare the prognosis of PE in patients of different age groups,
regarding the incidence of major unfavorable outcomes during
short and long-term follow-up, especially for subsequent cardio-
vascular events. Our report showed 3 and 6 mortality cases among
elderly and young patients, respectively. There was no difference
between these two groups in short-termmortality or severity of PE.
However, according to the results of our study, elderly patients had
a higher risk of subsequent acute myocardial infarction after acute
PE when compared to young patients in long-term follow-up. This
phenomenon has been described by Sorensen et al6 There is an
association between atherosclerotic disease and spontaneous
venous thrombosis, and this association is stronger in elderly
patients14. However, another study demonstrated that the inci-
dence of arterial cardiovascular events for all patients with PE did
not increase compared to patients without PE5. For this reason, the
relationship between SCVE after an episode of PE may need more
evaluation. Nevertheless, the ﬁndings in our study provide useful
information between young and elderly patients regarding the
mortality proﬁle and the risk for SCVE in cases with PE.
Another main objective of our study was to analyze the diag-
nostic interval and the initial clinical presenting symptoms. One
study showed that in symptomatic outpatients being considered
for possible PE, non-cancer-related thrombophilia, pleuritic chest
pain, and family history of venous thromboembolism, increase the
probability of PE or deep venous thrombosis15. However, in our
study, therewas no clinical presentation that showed a speciﬁc clue
in elderly patients with PE.5. Conclusion
Although the risk of subsequent myocardial infarction after
acute PE in the elderly is higher, there was no signiﬁcant differ-
ence noted in the overall SCVE between two groups in our study.
However, a limitation of our study is that the follow-up period
was not optimal. More long-term follow-up after PE may be
needed for more thorough research. The relationship between PE
and SCVE may also need further evaluation. Furthermore, our
study showed that diagnosis intervals in the elderly were more
widely variable, and the rate of late-diagnosis after 24 hours of
presentation had a higher timely trend in elderly patients when
compared with younger patients. Rapid and precise diagnosis of
PE in the emergency department remains a challenge for emer-
gency physicians, and the early diagnosis of PE is more difﬁcult in
the elderly.References
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